期刊文献+

CHO工程细胞(11G-S)悬浮培养的无血清培养基的设计 被引量:6

Serum-free medium for suspension culture of recombinant Chinese hamster ovary (11G-S) cells
原文传递
导出
摘要 以悬浮适应的表达重组尿激酶原(Pro-urokinase,pro-UK)CHO工程细胞系11G-S为对象,采用Plackett-Burman实验设计及响应面分析法,设计支持CHO工程细胞(11G-S)悬浮生长的无血清培养基。以细胞密度为评价指标,在单因素实验的基础上采用Plackett-Burman实验设计对影响细胞生长的培养基添加成分进行考察,确定了3种对细胞生长明显促进作用的培养基添加成分:胰岛素、转铁蛋白及腐胺。继而利用响应面法分析了这3种添加成分的最佳水平范围,设计了一种适用于CHO工程细胞(11G-S)悬浮培养的无血清培养基SFM-CHO-S。11G-S细胞在SFM-CHO-S批次悬浮培养的细胞最大生长密度达到4.12×106cells/mL,pro-UK的最大累积活性达到5614IU/mL,培养效果优于商品化的同类无血清培养基。 With suspension adapted recombinant Chinese hamster ovary (CHO) cell lines 11G-S expressing human pro-urokinase (pro-UK) as the object of study, a serum-free medium for the cultivation of recombinant CHO cells in suspension was formulated by using Plackett-Burman design and response surface methodology. The two-level Plackett-Burman design was used to evaluate the effect of 10 medium supplements on the growth of the llG-S cells in suspension culture. Among the 10 medium supplements, insulin, transferrin, and putrescine were identified as the most significant factors (P〈0.05). The response surface methodology with three factors and three levels was used to determine the optimal levels of these factors. And a serum-free medium, SFM-CHO-S for recombinant CHO cells suspension culture was formulated. The maximum cell density of 11G-S cells in SFM-CHO-S in suspension batch culture reached 4.12× 10^6 cells/mL with a maximum pro-UK activity at 5 614 IU/mL, which was superior to the commercial serum-free medium for recombinant CHO cells.
出处 《生物工程学报》 CAS CSCD 北大核心 2010年第8期1116-1122,共7页 Chinese Journal of Biotechnology
基金 "重大新药创制"科技重大专项资助课题(No.2009ZX09503-011)资助~~
关键词 CHO工程细胞 悬浮培养 无血清培养基 实验设计 recombinant Chinese hamster ovary cells, suspension culture, serum-free medium, medium design
  • 相关文献

参考文献12

  • 1Moreira AR. The evolution of protein expression and cell culture. Biopharm Int, 2007, 20(10): 56-65.
  • 2Dingermann T. Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J, 2008, 3(1): 90-97.
  • 3Bulter M. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.Appl Microbiol Biotechnol, 2005, 68(3): 283-291.
  • 4Jagschies G. Where is biopharmaceutical manufacturing heading. Biopharm lnt, 2008, 21(10): 72-88.
  • 5Even MS, Sandusky CB, Barnard ND. Serum-free hybridoma culture: ethical, scientific and safety considerations. Trends Biotechnol, 2006, 24(3): 105-108.
  • 6Keenan J, Pearson D, Clynes M. The role of recombinant proteins in the development of serum-free media.Cytotechnology, 2006, 50(1/3): 49-56.
  • 7刘兴茂,刘红,叶玲玲,李世崇,吴本传,王启伟,陈昭烈.中国仓鼠卵巢细胞的悬浮适应及代谢特征[J].生物技术通讯,2009,20(4):506-509. 被引量:4
  • 8Jespersen J, Astrup T. A study of the fibrin plate assay of fibrinolytic agents: optimal conditions, reproducibility and precision. Hamostasis, 1983, 13(5): 301-315.
  • 9Weuster-Botz D. Experimental design for fermentation media development: statistical design or global random search. JBiosci Bioeng, 2000, 90(5): 473-483.
  • 10De Alwis DM, Dutton RL, Scharer J, et al. Statistical methods in media optimization for batch and fed-batch animal cell culture. Bioprocess Biosyst Eng, 2007, 30(2): 107-113.

二级参考文献4

  • 1韩素文,俞炜源,李秀珍,唐红娣,方继明,黄翠芬.培养细胞分泌的血纤维蛋白溶酶原激活物的研究[J]军事医学科学院院刊,1987(02).
  • 2Yung-Shyeng Tsao,Russell Condon,Eugene Schaefer,Peggy Lio,Zhong Liu. Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells[J] 2001,Cytotechnology(3):189~198
  • 3H. J. Cruz,E. M. Dias,J. L. Moreira,M. J. T. Carrondo. Cell-dislodging methods under serum-free conditions[J] 1997,Applied Microbiology and Biotechnology(5):482~488
  • 4R.A. Taticek,K.A. McKenna,R.R. Granados,Michael L. Shuler. Rapid initiation of suspension cultures of Trichoplusia ni insect cells (TN 5B-1-4) using heparin[J] 1997,Biotechnology Techniques(4):237~240

共引文献3

同被引文献92

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部